Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury
Fatih Arslan, Ruenn Chai Lai, Mirjam B Smeets, Lars Akeroyd, Andre Choo, Eissa N E Aguor, Leo Timmers, Harold V van Rijen, Pieter A Doevendans, Gerard Pasterkamp, Sai Kiang Lim, Dominique P de Kleijn, Fatih Arslan, Ruenn Chai Lai, Mirjam B Smeets, Lars Akeroyd, Andre Choo, Eissa N E Aguor, Leo Timmers, Harold V van Rijen, Pieter A Doevendans, Gerard Pasterkamp, Sai Kiang Lim, Dominique P de Kleijn
Abstract
We have previously identified exosomes as the paracrine factor secreted by mesenchymal stem cells. Recently, we found that the key features of reperfusion injury, namely loss of ATP/NADH, increased oxidative stress and cell death were underpinned by proteomic deficiencies in ischemic/reperfused myocardium, and could be ameliorated by proteins in exosomes. To test this hypothesis in vivo, mice (C57Bl6/J) underwent 30 min ischemia, followed by reperfusion (I/R injury). Purified exosomes or saline was administered 5 min before reperfusion. Exosomes reduced infarct size by 45% compared to saline treatment. Langendorff experiments revealed that intact but not lysed exosomes enhanced viability of the ischemic/reperfused myocardium. Exosome treated animals exhibited significant preservation of left ventricular geometry and contractile performance during 28 days follow-up. Within an hour after reperfusion, exosome treatment increased levels of ATP and NADH, decreased oxidative stress, increased phosphorylated-Akt and phosphorylated-GSK-3β, and reduced phosphorylated-c-JNK in ischemic/reperfused hearts. Subsequently, both local and systemic inflammation were significantly reduced 24h after reperfusion. In conclusion, our study shows that intact exosomes restore bioenergetics, reduce oxidative stress and activate pro-survival signaling, thereby enhancing cardiac function and geometry after myocardial I/R injury. Hence, mesenchymal stem cell-derived exosomes are a potential adjuvant to reperfusion therapy for myocardial infarction.
Copyright © 2013 Elsevier B.V. All rights reserved.
Source: PubMed
Bevorstehende klinische Studien
-
NCT07945054Noch keine RekrutierungCharcot-Marie-Tooth-Krankheit (CMT)
-
NCT07908589Noch keine Rekrutierung
-
NCT07863024Rekrutierung
-
NCT07944755Noch keine RekrutierungKindesmissbrauch | Pflegeausbildung | Kindesvernachlässigung | Sexueller Missbrauch von Kindern
-
NCT07944573Noch keine Rekrutierung
-
NCT07885683RekrutierungHER2-positiver Brustkrebs
-
NCT07944950RekrutierungAngst vor der Geburt | Kaiserschnitt | LABOR PAİN
-
NCT07946991Rekrutierung
-
NCT07946133Noch keine RekrutierungZervikale Radikulopathie an der C6-Nervenwurzel
-
NCT07947186RekrutierungSchwangerschaftsverhütung | Männliche Verhütung | Verhütungsmittel | Prevention of Semen Exposure During Intercourse
-
NCT07944651Noch keine RekrutierungMantelzell-Lymphom (MCL) | Rezidiviertes/Refraktäres Mantelzell-Lymphom (MCL)